Cite
Park KC, Kim SM, Jeon JY, et al. Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer. Neoplasia. 2017;19(3):145-153doi: 10.1016/j.neo.2016.12.005.
Park, K. C., Kim, S. M., Jeon, J. Y., Kim, B. W., Kim, H. K., Chang, H. J., Lee, Y. S., Kim, S. Y., Choi, S. H., Park, C. S., & Chang, H. S. (2017). Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer. Neoplasia (New York, N.Y.), 19(3), 145-153. https://doi.org/10.1016/j.neo.2016.12.005
Park, Ki Cheong, et al. "Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer." Neoplasia (New York, N.Y.) vol. 19,3 (2017): 145-153. doi: https://doi.org/10.1016/j.neo.2016.12.005
Park KC, Kim SM, Jeon JY, Kim BW, Kim HK, Chang HJ, Lee YS, Kim SY, Choi SH, Park CS, Chang HS. Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer. Neoplasia. 2017 Mar;19(3):145-153. doi: 10.1016/j.neo.2016.12.005. Epub 2017 Jan 28. PMID: 28142087; PMCID: PMC5279904.
Copy
Download .nbib